Gossamer Bio Faces Class Action Lawsuit After Trial Failure Raises Questions#United_States#Class_Action#San_Francisco#Gossamer_Bio#seralutinib
Gossamer Bio Faces Class Action Lawsuit After Trial Failure Raises Questions
Gossamer Bio, Inc. investors may lead a class action lawsuit following significant losses after the company's trial results revealed undisclosed risks.
third-news.com
May 14, 2026 at 6:42 PM
Gossamer Bio Faces Class Action Lawsuit After Trial Failure Raises Questions#United_States#Class_Action#San_Francisco#Gossamer_Bio#seralutinib
Gossamer Bio, Inc. Shareholders Can Lead Securities Fraud Class Action After Losses#United_States#Class_Action#Securities_Fraud#Bensalem#Gossamer_Bio
Gossamer Bio, Inc. Shareholders Can Lead Securities Fraud Class Action After Losses
Shareholders of Gossamer Bio, Inc. have the opportunity to lead a class action lawsuit regarding securities fraud, after facing significant losses.
third-news.com
May 14, 2026 at 7:45 PM
Gossamer Bio, Inc. Shareholders Can Lead Securities Fraud Class Action After Losses#United_States#Class_Action#Securities_Fraud#Bensalem#Gossamer_Bio
Investors Alert: Legal Actions Filed Against Gossamer Bio, Inc. Over Shareholder Losses#United_States#New_York#Class_Action#Pomerantz_Law#Gossamer_Bio
Investors Alert: Legal Actions Filed Against Gossamer Bio, Inc. Over Shareholder Losses
Pomerantz Law Firm announces a class action lawsuit against Gossamer Bio, Inc., urging affected investors to take action before upcoming deadlines.
third-news.com
May 15, 2026 at 12:10 AM
Investors Alert: Legal Actions Filed Against Gossamer Bio, Inc. Over Shareholder Losses#United_States#New_York#Class_Action#Pomerantz_Law#Gossamer_Bio
Gossamer Bio Faces Securities Class Action as Deadline Approaches in June 2026#USA#New_York#Securities_Law#Faruqi_&_Faruqi#Gossamer_Bio
Gossamer Bio Faces Securities Class Action as Deadline Approaches in June 2026
Faruqi & Faruqi, LLP alerts investors on the upcoming June 2026 deadline for the class action lawsuit against Gossamer Bio, urging affected parties to respond.
third-news.com
May 14, 2026 at 3:12 PM
Gossamer Bio Faces Securities Class Action as Deadline Approaches in June 2026#USA#New_York#Securities_Law#Faruqi_&_Faruqi#Gossamer_Bio
Kuehn Law Investigates Potential Misrepresentation by Gossamer Bio, Inc. Management Regarding Financial Securities#USA#New_York#Kuehn_Law#Gossamer_Bio#seralutinib
Kuehn Law Investigates Potential Misrepresentation by Gossamer Bio, Inc. Management Regarding Financial Securities
Kuehn Law is probing potential breaches by Gossamer Bio Inc. executives related to Phase 3 study disclosures affecting shareholder investments.
third-news.com
August 10, 2026 at 1:28 PM
Kuehn Law Investigates Potential Misrepresentation by Gossamer Bio, Inc. Management Regarding Financial Securities#USA#New_York#Kuehn_Law#Gossamer_Bio#seralutinib
Investors Entangled in Gossamer Bio's Class Action: Key Deadline Approaching#None#Hagens_Berman#Gossamer_Bio#GOSS_Class_Action
Investors Entangled in Gossamer Bio's Class Action: Key Deadline Approaching
Hagens Berman notifies investors of a class action lawsuit against Gossamer Bio, with a major deadline looming for those affected.
third-news.com
June 1, 2026 at 9:36 AM
Investors Entangled in Gossamer Bio's Class Action: Key Deadline Approaching#None#Hagens_Berman#Gossamer_Bio#GOSS_Class_Action
Class Action Filed Against Gossamer Bio for Misleading Statements Impacting Investors#United_States#Los_Angeles#securities_lawsuit#DJS_Law_Group#Gossamer_Bio
Class Action Filed Against Gossamer Bio for Misleading Statements Impacting Investors
Gossamer Bio, Inc. faces a class action lawsuit for allegedly making false statements about its Phase 3 study, misleading investors. Details on how affected shareholders can participate are provided.
third-news.com
June 1, 2026 at 8:02 AM
Class Action Filed Against Gossamer Bio for Misleading Statements Impacting Investors#United_States#Los_Angeles#securities_lawsuit#DJS_Law_Group#Gossamer_Bio
Investors Alert: Join the Gossamer Bio Securities Fraud Lawsuit#United_States#Los_Angeles#Schall_Law_Firm#Securities_Fraud#Gossamer_Bio
Investors Alert: Join the Gossamer Bio Securities Fraud Lawsuit
Investors in Gossamer Bio, Inc. have the chance to lead a class action lawsuit over securities fraud. Connect with the Schall Law Firm now.
third-news.com
June 1, 2026 at 7:22 AM
Investors Alert: Join the Gossamer Bio Securities Fraud Lawsuit#United_States#Los_Angeles#Schall_Law_Firm#Securities_Fraud#Gossamer_Bio
Gossamer Bio Faces Class Action Lawsuit Over Concealed Risks Following Troubling Phase 3 Trial Results#USA#Class_Action#San_Francisco#Gossamer_Bio#PROSERA_Trial
Gossamer Bio Faces Class Action Lawsuit Over Concealed Risks Following Troubling Phase 3 Trial Results
Gossamer Bio, Inc. is embroiled in a class action lawsuit after revealing the Phase 3 PROSERA trial results, affecting investor trust and stock price significantly.
third-news.com
May 30, 2026 at 2:08 PM
Gossamer Bio Faces Class Action Lawsuit Over Concealed Risks Following Troubling Phase 3 Trial Results#USA#Class_Action#San_Francisco#Gossamer_Bio#PROSERA_Trial
Faruqi & Faruqi, LLP Reminds Gossamer Bio Investors of Key Legal Actions Ahead#USA#New_York#Securities_Class_Action#Faruqi_&_Faruqi#Gossamer_Bio
Faruqi & Faruqi, LLP Reminds Gossamer Bio Investors of Key Legal Actions Ahead
Faruqi & Faruqi, LLP has issued an important reminder for Gossamer Bio investors regarding the upcoming class action deadline of June 1, 2026. This comes after significant stock price drops following trial results.
third-news.com
May 29, 2026 at 1:48 PM
Faruqi & Faruqi, LLP Reminds Gossamer Bio Investors of Key Legal Actions Ahead#USA#New_York#Securities_Class_Action#Faruqi_&_Faruqi#Gossamer_Bio
Investors in Gossamer Bio Have Chance to Participate in Securities Fraud Case#USA#New_York#Securities_Fraud#Rosen_Law_Firm#Gossamer_Bio
Investors in Gossamer Bio Have Chance to Participate in Securities Fraud Case
Gossamer Bio investors facing losses over $100,000 can lead a securities fraud lawsuit. Join the class action before the June 1 deadline for potential compensation.
third-news.com
May 28, 2026 at 11:16 PM
Investors in Gossamer Bio Have Chance to Participate in Securities Fraud Case#USA#New_York#Securities_Fraud#Rosen_Law_Firm#Gossamer_Bio
Potential Legal Action for Gossamer Bio Investors Facing Significant Losses in Share Value#None#Securities_Fraud#Investor_Rights#Gossamer_Bio
Potential Legal Action for Gossamer Bio Investors Facing Significant Losses in Share Value
Gossamer Bio investors who suffered losses may now lead a securities fraud class action lawsuit. Legal steps must be taken before the upcoming deadline to seek restitution.
third-news.com
May 28, 2026 at 7:39 PM
Potential Legal Action for Gossamer Bio Investors Facing Significant Losses in Share Value#None#Securities_Fraud#Investor_Rights#Gossamer_Bio
Gossamer Bio Class Action Lawsuit: What Investors Need to Know#USA#New_York#Class_Action#Pomerantz_LLP#Gossamer_Bio
Gossamer Bio Class Action Lawsuit: What Investors Need to Know
Pomerantz LLP has initiated a class action lawsuit against Gossamer Bio, Inc. for investor losses, following poor performance data release. Key deadlines are approaching.
third-news.com
May 28, 2026 at 2:47 PM
Gossamer Bio Class Action Lawsuit: What Investors Need to Know#USA#New_York#Class_Action#Pomerantz_LLP#Gossamer_Bio
Investors Unite as Gossamer Bio Faces Class Action Lawsuit Over Concealed Risks#United_States#Class_Action#San_Francisco#Securities_Laws#Gossamer_Bio
Investors Unite as Gossamer Bio Faces Class Action Lawsuit Over Concealed Risks
Gossamer Bio investors, facing significant losses, may lead a class action after executives allegedly misrepresented a clinical trial's risks, revealing troubling outcomes.
third-news.com
May 28, 2026 at 1:56 PM
Investors Unite as Gossamer Bio Faces Class Action Lawsuit Over Concealed Risks#United_States#Class_Action#San_Francisco#Securities_Laws#Gossamer_Bio
Gossamer Bio Investors Facing Losses Can Take Legal Action Against Securities Fraud#USA#Los_Angeles#investors#Fraud_Lawsuit#Gossamer_Bio
Gossamer Bio Investors Facing Losses Can Take Legal Action Against Securities Fraud
Investors who lost money on their Gossamer Bio shares have a chance to lead a class action lawsuit over alleged securities fraud. Act now to learn more!
third-news.com
May 27, 2026 at 4:12 PM
Gossamer Bio Investors Facing Losses Can Take Legal Action Against Securities Fraud#USA#Los_Angeles#investors#Fraud_Lawsuit#Gossamer_Bio
Investors Encouraged to Lead Class Action Against Gossamer Bio, Inc. Following Allegations of Securities Fraud#United_States#Los_Angeles#Schall_Law_Firm#Securities_Fraud#Gossamer_Bio
Investors Encouraged to Lead Class Action Against Gossamer Bio, Inc. Following Allegations of Securities Fraud
The Schall Law Firm announces a class action lawsuit against Gossamer Bio, Inc., inviting affected investors to join the case to recover potential losses. The lawsuit alleges securities fraud violations.
third-news.com
May 27, 2026 at 7:53 AM
Investors Encouraged to Lead Class Action Against Gossamer Bio, Inc. Following Allegations of Securities Fraud#United_States#Los_Angeles#Schall_Law_Firm#Securities_Fraud#Gossamer_Bio
Gossamer Bio, Inc. Faces Class Action Lawsuit Over Securities Violations#United_States#Class_Action#Los_Angeles#DJS_Law_Group#Gossamer_Bio
Gossamer Bio, Inc. Faces Class Action Lawsuit Over Securities Violations
Gossamer Bio, Inc. is entangled in a class action lawsuit due to alleged violations of securities laws. Investors are urged to seek legal advice to understand their options.
third-news.com
May 27, 2026 at 6:19 AM
Gossamer Bio, Inc. Faces Class Action Lawsuit Over Securities Violations#United_States#Class_Action#Los_Angeles#DJS_Law_Group#Gossamer_Bio
Gossamer Bio, Inc. Investors Alert: Join Class Action Lawsuit Against the Company#United_States#New_York#Class_Action#Gross_Law_Firm#Gossamer_Bio
Gossamer Bio, Inc. Investors Alert: Join Class Action Lawsuit Against the Company
Shareholders of Gossamer Bio, Inc. may qualify to lead a class action lawsuit after significant losses. Learn how to participate and protect your rights.
third-news.com
May 26, 2026 at 1:44 PM
Gossamer Bio, Inc. Investors Alert: Join Class Action Lawsuit Against the Company#United_States#New_York#Class_Action#Gross_Law_Firm#Gossamer_Bio
Gossamer Bio Faces Class Action as Investors Allege Concealment of Risks in PAH Trial#United_States#Class_Action#San_Francisco#Gossamer_Bio#PROSERA
Gossamer Bio Faces Class Action as Investors Allege Concealment of Risks in PAH Trial
Gossamer Bio, Inc. is under scrutiny as investors file a class action lawsuit alleging concealed risks regarding the PROSERA trial. The fallout from failed trial results has caused an 80% drop in stock prices.
third-news.com
May 26, 2026 at 1:14 PM
Gossamer Bio Faces Class Action as Investors Allege Concealment of Risks in PAH Trial#United_States#Class_Action#San_Francisco#Gossamer_Bio#PROSERA
Gossamer Bio Faces Securities Class Action After Phase 3 Trial Failure Leads to 80% Stock Plunge#USA#San_Francisco#Gossamer_Bio#seralutinib#PROSERA
Gossamer Bio Faces Securities Class Action After Phase 3 Trial Failure Leads to 80% Stock Plunge
A class action lawsuit against Gossamer Bio arises after a staggering 80% drop in stock due to trial failures on their drug for pulmonary arterial hypertension. Investors seek justice.
third-news.com
May 23, 2026 at 1:50 PM
Gossamer Bio Faces Securities Class Action After Phase 3 Trial Failure Leads to 80% Stock Plunge#USA#San_Francisco#Gossamer_Bio#seralutinib#PROSERA
Gossamer Bio Faces Class Action Lawsuit Amid Securities Fraud Allegations#USA#San_Diego#Robbins_LLP#Securities_Fraud#Gossamer_Bio
Gossamer Bio Faces Class Action Lawsuit Amid Securities Fraud Allegations
Gossamer Bio, Inc. shareholders may be eligible for a class action after recent allegations of misleading statements about its clinical trials. Learn how to act.
third-news.com
May 22, 2026 at 10:59 PM
Gossamer Bio Faces Class Action Lawsuit Amid Securities Fraud Allegations#USA#San_Diego#Robbins_LLP#Securities_Fraud#Gossamer_Bio
Gossamer Bio, Inc. Shareholders Have Chance to Lead Class Action Lawsuit Over Securities Fraud#USA#Class_Action#Los_Angeles#Securities_Fraud#Gossamer_Bio
Gossamer Bio, Inc. Shareholders Have Chance to Lead Class Action Lawsuit Over Securities Fraud
Gossamer Bio, Inc. is facing a class action lawsuit due to allegations of securities fraud. Shareholders who incurred losses can participate in the case.
third-news.com
May 22, 2026 at 6:58 PM
Gossamer Bio, Inc. Shareholders Have Chance to Lead Class Action Lawsuit Over Securities Fraud#USA#Class_Action#Los_Angeles#Securities_Fraud#Gossamer_Bio
Pomerantz Law Firm Notifies Investors of Class Action Against Gossamer Bio Over Investment Losses#United_States#New_York#Class_Action#Pomerantz_LLP#Gossamer_Bio
Pomerantz Law Firm Notifies Investors of Class Action Against Gossamer Bio Over Investment Losses
The Pomerantz Law Firm is alerting investors about a class action lawsuit against Gossamer Bio, Inc. concerning significant investment losses. Key deadlines are approaching.
third-news.com
May 21, 2026 at 7:23 PM
Pomerantz Law Firm Notifies Investors of Class Action Against Gossamer Bio Over Investment Losses#United_States#New_York#Class_Action#Pomerantz_LLP#Gossamer_Bio
Gossamer Bio Investors Consider Class Action Amid Alleged Securities Fraud Claims#USA#New_York#Class_Action#Securities_Fraud#Gossamer_Bio
Gossamer Bio Investors Consider Class Action Amid Alleged Securities Fraud Claims
Investors of Gossamer Bio, Inc. may pursue a class action lawsuit alleging securities fraud following significant stock losses attributed to concealed risks during clinical trials.
third-news.com
May 21, 2026 at 1:37 PM
Gossamer Bio Investors Consider Class Action Amid Alleged Securities Fraud Claims#USA#New_York#Class_Action#Securities_Fraud#Gossamer_Bio
Gossamer Bio, Inc. Faces Class Action Lawsuit After Dramatic Stock Plunge Due to Phase 3 Trial Failure#USA#San_Francisco#Gossamer_Bio#PAH#seralutinib
Gossamer Bio, Inc. Faces Class Action Lawsuit After Dramatic Stock Plunge Due to Phase 3 Trial Failure
Following an 80% stock drop due to the failure of its Phase 3 trial, Gossamer Bio, Inc. is facing a securities class action lawsuit seeking to represent distressed investors.
third-news.com
May 21, 2026 at 1:24 PM
Gossamer Bio, Inc. Faces Class Action Lawsuit After Dramatic Stock Plunge Due to Phase 3 Trial Failure#USA#San_Francisco#Gossamer_Bio#PAH#seralutinib